Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125717862 | 12571786 | 2 | F | 20160720 | 20160719 | 20160722 | EXP | JP-BAYER-2016-136801 | BAYER | TERASAKA K. EVALUATION OF EIGHT CASES OF CEREBRAL HAEMORRHAGE DURING ANTITHROMBOTIC THERAPY.. THE 53RD ANNUAL MEETING OF THE JAPANESE ASSOCIATION OF REHABILITATION MEDICINE. 2016;XX:1265 | 78.00 | YR | E | F | Y | 0.00000 | 20160722 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125717862 | 12571786 | 1 | PS | Bayaspirin | ASPIRIN | 1 | Oral | UNK | 21317 | GASTRO-RESISTANT TABLET | |||||||||
| 125717862 | 12571786 | 2 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | UNK | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125717862 | 12571786 | 1 | Antiplatelet therapy |
| 125717862 | 12571786 | 2 | Antiplatelet therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125717862 | 12571786 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125717862 | 12571786 | Drug administration error | |
| 125717862 | 12571786 | Labelled drug-drug interaction medication error | |
| 125717862 | 12571786 | Putamen haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |